Clinical Trial Update: Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 clinical trial evaluated propranolol for hepatic hemangioma, focusing on efficacy assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Hemangioma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Hemangioma Liver | Phase 1, Phase 2 | Status: TERMINATED